Cargando…

Circulating tumor DNA analysis: potential to revise adjuvant therapy for stage II colorectal cancer

Detalles Bibliográficos
Autores principales:	Zhu, Ning, Hu, Hanguang, Yuan, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445072/ https://www.ncbi.nlm.nih.gov/pubmed/36064813 http://dx.doi.org/10.1038/s41392-022-01164-y

Ejemplares similares

Circulating tumor DNA moves further into the spotlight
por: Sausen, Mark, et al.
Publicado: (2014)

Antibiotic adjuvants: identification and clinical use
por: Bernal, Patricia, et al.
Publicado: (2013)

Circadian‐rhythm‐regulating hormones: Key factors to regulate breast cancer metastasis via circulating tumor cells
por: Liu, Chenguang, et al.
Publicado: (2022)

Revising immune cell coordination: Origins and importance of single‐cell variation
por: Van Eyndhoven, Laura C., et al.
Publicado: (2022)

Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer
por: Yuan, Shu‐Qiang, et al.
Publicado: (2023)

Tumour travel tours – Why circulating cancer cells value company
por: Häfner, Sophia Julia
Publicado: (2020)

Innate lymphoid cells and cancer: Role in tumor progression and inhibition
por: Yuan, Xiaodong, et al.
Publicado: (2021)

Spinal cord concussion: studying the potential risks of repetitive injury
por: Fischer, Itzhak, et al.
Publicado: (2016)

Tumor‐derived microparticles in tumor immunology and immunotherapy
por: Ma, Jingwei, et al.
Publicado: (2020)

NIR-II thiopyrylium dyads guided photodynamic inactivation of Coronavirus
por: Xu, Yunjie, et al.
Publicado: (2023)

Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer
por: Yuan, Zhen, et al.
Publicado: (2022)

Futility versus utility of marrow assessment in initial Ewing sarcoma staging workup
por: Anderson, Peter M
Publicado: (2015)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

Highlight: Bacteria Shed DNA as They Adapt to Hot Temperatures
por: Venton, Danielle
Publicado: (2013)

Unraveling the Dynamics of Antibody-Antigen Interaction by DNA Origami
por: Nie, Zhou
Publicado: (2020)

Drug transporter regulation in tumors by DNA methylation
por: Zolk, Oliver, et al.
Publicado: (2012)

Highlight—Making It Big: Salamanders Keep DNA Near and Dear
por: Venton, Danielle
Publicado: (2012)

Radiotherapy and the tumor microenvironment: The “macro” picture
por: Walton, Emma Louise
Publicado: (2017)

A novel prognostic prediction tool for postoperative recurrence in patients with stage II/III colon cancer
por: Ma, Jian, et al.
Publicado: (2019)

Highlight—“Junk DNA” No More: Repetitive Elements as Vital Sources of Flatworm Variation
por: McGrath, Casey
Publicado: (2021)

ecDNA within tumors: a new mechanism that drives tumor heterogeneity and drug resistance
por: Zeng, Xixi, et al.
Publicado: (2020)

MXene-Graphene Composites: A Perspective on Biomedical Potentials
por: Mostafavi, Ebrahim, et al.
Publicado: (2022)

Switching off DNA repair—how colorectal cancer evades targeted therapies through adaptive mutability
por: Fahrer, Jörg
Publicado: (2020)

The thioredoxin system: Balancing redox responses in immune cells and tumors
por: Muri, Jonathan, et al.
Publicado: (2022)

Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients
por: Yang, Ying-Chi, et al.
Publicado: (2018)

Sequence capture by hybridization reveals elusive hydrocarbon degradation potential
por: von Netzer, Frederick
Publicado: (2017)

Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase
por: Xu, Yechun, et al.
Publicado: (2020)

CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer
por: Taniguchi, Hiroya, et al.
Publicado: (2021)

Iron, oxygen, and the pulmonary circulation
por: Frise, Matthew C., et al.
Publicado: (2015)

Make immunological peace not war: Potential applications of tolerogenic dendritic cells
por: Walton, Emma Louise
Publicado: (2017)

Targeting PCSK9: a promising adjuvant strategy in cancer immunotherapy
por: Almeida, Catarina R., et al.
Publicado: (2021)

Regenerative potential of targeting glycogen synthase kinase-3 signaling in neural tissues
por: Jung, Eui-Man, et al.
Publicado: (2015)

Tumor‐derived extracellular vesicles and particles (EVPs): pivotal vectors in driving metabolic reprogramming
por: Su, Xinming, et al.
Publicado: (2023)

Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma
por: Liu, Li-Ting, et al.
Publicado: (2019)

Cancer mutation signatures, DNA damage mechanisms, and potential clinical implications
por: Harris, Reuben S
Publicado: (2013)

Pancreatic tumor initiation: the potential role of IL-33
por: Huang, Xing, et al.
Publicado: (2021)

The neuroprotective effects of human growth hormone as a potential treatment for amyotrophic lateral sclerosis
por: Chung, Jin-Young, et al.
Publicado: (2015)

Alzheimer’s disease: targeting the peripheral circulation
por: Liu, Zhi-Hao, et al.
Publicado: (2023)

SMIP-30, a potent and selective PPM1A inhibitor with potential to treat tuberculosis
por: Xu, Shujing, et al.
Publicado: (2022)

‘Nur'turing tumor T cell tolerance and exhaustion: novel function for Nuclear Receptor Nur77 in immunity
por: Lith, Sanne C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2tntf1afmvendcneasqind88c9